Susan Prendeville1, Ciara Ryan1, Linda Feeley1, Fionnuala O'Connell1, Tara Jane Browne1, Martin J O'Sullivan2, Michael W Bennett3. 1. Department of Histopathology, Cork University Hospital, Wilton, Cork, Ireland. 2. Department of Surgery, Cork University Hospital, Wilton, Cork, Ireland; BreastCheck Southern Unit (National Cancer Screening Service), Infirmary Road, Cork, Ireland. 3. Department of Histopathology, Cork University Hospital, Wilton, Cork, Ireland; BreastCheck Southern Unit (National Cancer Screening Service), Infirmary Road, Cork, Ireland. Electronic address: Michael.bennett@hse.ie.
Abstract
INTRODUCTION: The role of sentinel lymph node biopsy (SLNB) in ductal carcinoma in situ (DCIS) is controversial. This study evaluates the risk of clinically relevant SLN metastasis following a core needle biopsy (CNB) diagnosis of pure DCIS. MATERIALS AND METHODS: Cases that underwent SLNB following a CNB diagnosis of pure DCIS at our institution over a 4.5 year period were evaluated. Parameters including the DCIS characteristics on CNB, the rate of upstaging to invasive carcinoma at excision and the SLNB result were recorded. RESULTS: Of 296 patients with a CNB diagnosis DCIS, 181 had SLNB (62%). The rate of invasion at excision in those undergoing SLNB was 30% (54/181). SLN metastasis was detected in 7/181 cases (4%), including 6 cases with isolated tumour cells only (3.5%) and only 1 case with a macro-metastatic deposit (0.5%). CONCLUSION: The risk of clinically significant SLN metastasis following a CNB diagnosis of DCIS is extremely low, despite a relatively high rate of upstaging to invasive carcinoma at excision. Our findings support the opinion that SLNB is not warranted following a CNB diagnosis of DCIS, particularly for those patients undergoing breast conservation surgery.
INTRODUCTION: The role of sentinel lymph node biopsy (SLNB) in ductal carcinoma in situ (DCIS) is controversial. This study evaluates the risk of clinically relevant SLN metastasis following a core needle biopsy (CNB) diagnosis of pure DCIS. MATERIALS AND METHODS: Cases that underwent SLNB following a CNB diagnosis of pure DCIS at our institution over a 4.5 year period were evaluated. Parameters including the DCIS characteristics on CNB, the rate of upstaging to invasive carcinoma at excision and the SLNB result were recorded. RESULTS: Of 296 patients with a CNB diagnosis DCIS, 181 had SLNB (62%). The rate of invasion at excision in those undergoing SLNB was 30% (54/181). SLN metastasis was detected in 7/181 cases (4%), including 6 cases with isolated tumour cells only (3.5%) and only 1 case with a macro-metastatic deposit (0.5%). CONCLUSION: The risk of clinically significant SLN metastasis following a CNB diagnosis of DCIS is extremely low, despite a relatively high rate of upstaging to invasive carcinoma at excision. Our findings support the opinion that SLNB is not warranted following a CNB diagnosis of DCIS, particularly for those patients undergoing breast conservation surgery.
Authors: L M van Roozendaal; B Goorts; M Klinkert; K B M I Keymeulen; B De Vries; L J A Strobbe; C A P Wauters; Y E van Riet; E Degreef; E J T Rutgers; J Wesseling; M L Smidt Journal: Breast Cancer Res Treat Date: 2016-04-15 Impact factor: 4.872
Authors: Sanghwa Kim; Jihong Kim; Hyung Seok Park; Ha Yan Kim; Kwanbum Lee; Jeea Lee; Haemin Lee; Jee Ye Kim; Seung Il Kim; Young Up Cho; Byeong Woo Park Journal: Yonsei Med J Date: 2019-11 Impact factor: 2.759
Authors: Peiyin Hung; Shi-Yi Wang; Brigid K Killelea; Sarah S Mougalian; Suzanne B Evans; Tannaz Sedghi; Cary P Gross Journal: JNCI Cancer Spectr Date: 2019-08-07